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Available online 14 September 2008Studies of established schizophreniahave consistently found that cognitive functionpredicts social
and clinical outcomes. The ﬁndings from ﬁrst-episode studies have beenmore variable, with only
some studies reporting predictive relationships. We tested the possibility that an index of general
cognitive ability, IQ, may be a more sensitive and reliable predictor of outcome in ﬁrst-episode
schizophrenia than speciﬁc measures of memory and executive function. Fifty-four patients with
ﬁrst-episode schizophrenia or schizoaffective disorder were assessed for cognitive and social
function as well as symptoms at three time points over the four years following ﬁrst presentation
of their psychotic illness. Regression analyses were performed to determine whether IQ and
speciﬁc neuropsychological measures at ﬁrst episode and one-year follow-up predicted four-year
social function and residual symptoms. The effects of premorbid and concurrent IQ on outcome
were also assessed. Premorbid IQ and IQ at each assessment signiﬁcantly predicted social function
at four-year follow-up. This relationship remained signiﬁcant after the social function or symptom
scores at ﬁrst presentation were accounted for in the regression. Speciﬁc measures predicted
certain domains of social function, but these were weaker and less consistent than IQ. The
predictive values of cognition on residual symptomswere less strong; themost consistent ﬁnding
was a relationship between IQ and the negative syndrome. This study suggests that early in the
course of schizophrenia, general cognitive ability, as measured by IQ, is a more sensitive and
reliable predictor of functional outcome than measures of speciﬁc ability.
© 2008 Elsevier B.V. Open access under CC BY license. Keywords:
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Schizophrenia is a complex neurodevelopmental disorder
with cognitive impairment as a core feature (Joyce and Huddy,
2004). The hypothesis that poor clinical and social outcome is
related to the degree of impairment in cognitive function
stems from systematic reviews of cross-sectional studies of
patients with established schizophrenia (Green, 1996; Green
et al., 2000). The results of longitudinal studies, whichof Medicine, Charing
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son),
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Y license. assessed patients entering rehabilitation schemes or continu-
ing with usual treatment, support this view. With only one
exception (Norman et al., 1999), these studies have found that
at least some aspects of cognitive function predict outcome
between 6 months and 15 years later (Brekke et al., 2005;
Bryson and Bell, 2003; Dickerson et al., 1999; Fujii and Wylie,
2003; Gold, 2004; Jaeger et al., 2003; Prouteau et al., 2005;
Smith et al., 2002; Velligan et al., 2000;Woonings et al., 2003).
An understanding of the predictors of outcome at illness
onset is particularly important because of the potential to
shape early interventions. However, the ﬁndings of long-
itudinal ﬁrst-episode studies are less consistent than those in
patients with established schizophrenia. Whereas some
studies assessing outcome up to 10 years after illness onset
have found signiﬁcant cognitive predictors at the time of the
ﬁrst episode (Holthausen et al., 2007; Milev et al., 2005),
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Verdoux et al., 2002). Some prospective studies have
measured cognitive function at different time points follow-
ing psychosis onset, as well as outcome, and found that
concurrent but not previous cognition was associated with
social function (Addington et al., 2005; Malla et al., 2002;
Stirling et al., 2003). These ﬁndings suggest that neuropsy-
chological measures in the early stages of schizophrenia may
not be reliable predictors of outcome.
Most studies in this area have examined the impact of speciﬁc
domains of cognitive function on outcome, such as memory,
attention and executive function. Few have incorporated IQ as a
measure of general ability (Carlsson et al., 2006; Fujii andWylie,
2003;Gold et al., 2002; vanWinkel et al., 2007). This is surprising
since IQ decrements are widely reported and premorbid IQ is
regarded as a risk factor for the subsequent development of
schizophrenia (Badcocket al., 2005;David et al.,1997; Fuller et al.,
2002; Jones et al., 1994; Joyce et al., 2005; Kremen et al., 1998;
Weickert et al., 2000). Gold et al. (2002) in a study of established
schizophrenia found that out of a wide variety of measures, IQ
had the highest correlation with total hours worked over the
subsequent 12months. First-episode studies have also found that
premorbid IQ and IQ at ﬁrst episode are signiﬁcant predictors of
outcome (Carlsson et al., 2006; van Winkel et al., 2007).
In the current study, we examined the effect of premorbid
IQ, and IQ at three assessment periods – ﬁrst episode, one and
four-year follow-up – on social and clinical outcome at the
four-year follow-up assessment. We also examined the effect
of more speciﬁc measures of neuropsychological performance
in the domains of memory and executive function. We were
able to test the stability of neuropsychological measures as
predictors of subsequent outcome and whether previous or
concurrent measures and speciﬁc or general abilities were
better in this regard.
2. Materials and methods
2.1. Subjects
The patients were recruited as part of a longitudinal study
of ﬁrst-episode psychosis in West London and were eligible if
aged between 16 and 55 years, presenting from the commu-
nity to mental health services with a psychotic illness for the
ﬁrst time and had no more than 12 weeks cumulative
exposure to antipsychotic medication. Fifty-four patients (43
male, 10 female) completed 3 assessments: at presentation
with their ﬁrst psychotic episode and a mean of 17 months
(one-year follow-up) and 52 months (four-year follow-up)
later. Fifty-two had a DSMIV diagnosis of schizophrenia and
two of schizoaffective disorder at the four-year follow-up
assessment. At the time of initial assessment, six were not
being prescribed antipsychotic medication, 27 were pre-
scribed ﬁrst-generation and 19 second-generation antipsy-
chotics, and two were prescribed a combination of both.
2.2. Clinical assessments
Patients were assessed with the Scales for the Assessment
of Positive and Negative Symptoms (SAPS: Andreasen, 1984;
SANS: Andreasen,1983). Scores for the three symptomderived
syndromes of schizophrenia (positive, negative, disorganisa-tion; Liddle and Barnes,1990)were calculated for each patient.
Social function was assessed with the Social Function Scale
(SFS), a 79-item, self-report scale, which Birchwood et al.
(1990) showed to be a reliable, valid and sensitive measure of
social functioning in individuals with schizophrenia. Indivi-
duals rate their abilities in seven areas of social function
(activation-engagement, interpersonal communication, fre-
quency of activities of daily living, competence at activities of
daily living, participation in social activities, participation in
recreational activities, and employment or occupational
activity) to provide subscale scores and a global score.
2.3. Neuropsychological assessments
Premorbid IQ was estimated using the Revised National
Adult Reading Test (NART: Nelson and Willison, 1991). Two
patients did not undergo assessment with the NART as they
were dyslexic. Current IQ was calculated from four subtests of
theWechsler Adult Intelligence Scale-Revised (WAIS-R:Wechs-
ler, 1997; Missar et al., 1994). Memory and executive functions
were measured with computerised tests from the Cambridge
AutomatedNeuropsychological Test Battery (CANTAB: Sahakian
and Owen, 1992) as follows: Pattern recognition memory — 24
single abstract patterns are shown sequentially followed by
forced choice recognition trials. Total correct was used as an
indexof recognitionmemory; Spatial workingmemory— this is a
self-ordered search task which measures the ability to remem-
ber the location of previously found ‘tokens’while searching for
new tokens. An error occurs when a participant returns to the
locationwhere a tokenhas alreadybeen found. Total errorswere
used as an index of the ability to manipulate information in
working memory; Spatial Span — this measures the ability to
remember the order of sequences of coloured squares on the
screen presented in increasing numbers. The highest number
recalled correctly was used as an index of working memory
span; Stockings of Cambridge — this is an analogue of the Tower
of London (Shallice, 1982). On trials which vary in difﬁculty,
subjects move coloured ‘balls’ in an arrangement displayed on
the screen to match a goal arrangement. Planning was indexed
by the number of problems solved in the minimum number of
moves possible. Response times are recorded during planning
trials and also during yoked control trials that mimic the exact
sequenceofmoves generated by the subject duringplanning. An
index of information processing speed or ‘thinking time’ was
derived by subtracting the time taken to initiate theﬁrstmove in
the control trial from that in the equivalent planning trial. At-
tentional set shifting— this test disambiguates the psychological
processes contributing to performance of the Wisconsin Card
Sorting Test. Participants are required to deduce a rule which
governs the ‘correct’ response in a series of visual discrimina-
tions. Once correct responding is established, the ‘rule’ required
for correct responding is changed.Weused thenumber of errors
made on early stages of the task as an indexof rule learning. At a
later stage the features governing the rule are changed and
participants are required to switch attentional set for correct
responding. Errors at this stage were used as an index set-
shifting ability.
In summary, the neuropsychological measures used as
predictors of four-year social function and symptomswere: IQ,
working memory span and manipulation, recognition mem-
ory, rule learning, set shifting, planning and thinking time.
Table 1
Mean cognitive scores as measured at the three assessments
Measure First episode
score
One-year
follow-up score
Four-year
follow-up score
Premorbid IQ 100.31 (10.92)
Current IQ 94.04 (14.86) 96.24 (15.16) 92.35 (24.35)
Recognition
memory
20.80 (2.80) 20.71 (3.19) 19.87 (3.28)
Working memory
manipulation
29.25 (19.99) 27.07 (5.82) 30.83 (18.56)
Working memory
span
5.38 (1.14) 5.82 (1.37) 5.87 (1.38)
Planning 7.47 (2.07) 8.24 (2.13) 8.24 (1.95)
Thinking time 5677 (3221) 5946 (3273) 8216 (5970)
Set shifting 10.78 (10.06) 12.53 (11.09) 9.08 (9.40)
Rule learning 11.18 (9.59) 15.48 (25.17) 7.02 (4.34)
Standard deviations are shown in parentheses.
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Seven percent of the neuropsychological data points were
missing, accounted for by non-completion of test procedures.
Missing data analyses using regression, based on the repeatedTable 2
Results of linear and logistic regression analyses for four-year follow-up SFS global
Four-year clinical/SFS dependent variable First-episode neuropsychological m
Signiﬁcant cognitive predictors
SFS Global score IQ: t=3.43, p=0.001
Thinking time: t=−2.37, p=0.022
Activation-engagement Thinking time: t=−3.15, p=0.003
IQ t=2.14, p=0.038
Interpersonal communication Thinking time: t=−2.14, p=0.038
Set shifting: t=−1.71, p=0.095
Recog memory: t=2.00, p=0.052
WM manipulation: t=2.46, p=0.0
IQ: t=2.14, p=0.038
Frequency of activities of daily living IQ: t=3.56, p=0.001
Competence at activities
of daily living
Span: t=2.63, p=0.012
Participation in recreational activities Rule learning: t=−1.95, p=0.057
Recognition memory: t=1.90, p=0.0
Participation in social
activities
Rule learning: t=−2.04, p=0.047
Occupational activity IQ: t=3.11, p=0.003
Negative syndrome IQ: Wald=4.44, p=0.035, odds ratio
Recognition memory: Wald=3.98
p=0.046, odds ratio=0.50
Thinking time: Wald=5.11, p=0.0
odds ratio=2.12
Positive syndrome Thinking time: Wald=4.58, p=0.0
odds ratio=1.46
Disorganisation syndrome Recognition memory: Wald=8.25
p=0.004,
odds ratio=0.70
Corresponding ﬁrst episode scores were entered as a predictor in the ﬁrst block and s
Models employing both ﬁrst episode and one-year follow-up neuropsychological mmeasures scores for each given test variable, were used to
impute these missing values.
At initial assessment, there was a sufﬁcient range of values
for each clinical syndrome score to allow for the variable to be
continuous. However, at one-year and four-year follow-up,
the scores were non-normally distributed. For these two time
points the scores were dichotomised for each syndrome as
present or absent. Thinking time was transformed to log10 in
order to return the distribution to normal.
To determine whether cognitive functions predicted later
outcome, hierarchical regression analyses were performed
with four-year follow-up clinical or social function measures
as the dependent variable. The corresponding measure at
initial assessment was entered as a predictor in the ﬁrst block
and all neuropsychological measures were entered as poten-
tial predictors in the second block using stepwise entry
criteria. These regression analyses were linear for social
function measures and logistic for syndrome scores. For all
stepwise regression analyses the criterion for entry was
pb0.10. In separate regressions, we examined the effect of
initial and one-year follow-up neuropsychological measures
on four-year social function or syndrome scores.and domain scores and clinical syndrome scores
easures One-year follow-up neuropsychological measures
Model ﬁt Signiﬁcant cognitive predictors Model ﬁt
r2adj=0.24 IQ: t=2.73, p=0.009 r2adj=0.12
F3,48=6.06 F2,48=4.11
p=0.001 p=0.023
r2adj=0.23 Thinking time: t=−2.19, p=0.035 r2adj=0.10
F3,48=5.83 F2,48=3.60
p=0.002 p=0.035
r2adj=0.32 WMmanipulation: t=1.98, p=0.054 r2adj=0.08
F6,48=4.71 F1,48= .316
p=0.001 p=0.052
18
r2adj=0.19 IQ: t=3.84, pb0.001 r2adj=0.23
F2,48=6.48 Rule learning: t=2.34, 0.024 F3,48=5.72
p=0.003 p=0.002
r2adj=0.09 WMmanipulation: t=2.10, p=0.041 r2adj=0.16
F2,48=3.47 Set shifting: t=2.46, p=0.018 F4,48=3.33
p=0.040 WM span: t=1.83, p=0.074 p=0.018
r2adj=0.13 None r2adj=0.00
64 F3,48=3.31
p=0.029
F2,48=0.31
p=0.578
r2adj=0.08 WMmanipulation: t=2.38, p=0.022 r2adj=0.10
F2,48=2.99 Planning: t=−1.83, 0.073 F3,48=2.86
p=0.060 p=0.047
r2adj=0.16 IQ: t=3.40, pb0.001 r2adj=0.22
F2,48=5.42 Planning: t=−2.73, p=0.009 F3,48=5.51
p=0.008 p=0.003
=0.93 Nagelkerke
r2=0.50
Set shifting: Wald=3.83, p=0.05,
odds ratio=1.09
Nagelkerke
r2=0.10,
24,
32, Nagelkerke
r2=0.14
None
, Nagelkerke
r2=0.25
Planning: Wald χ2=5.16, p=0.023,
odds ratio=0.70
Nagelkerke
r2=0.15
tepwise entry of individual neuropsychological variables in the second block.
easures are contrasted. WM=working memory.
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Table 1 shows the mean performance of the patient group
on all cognitive measures at each assessment. Pearson’s
correlations for the cognitive test scores at initial assessment
showed that current IQ was highly associated with recogni-
tion memory (r=0.44, pb0.001), working memory manipula-
tion (r=0.45, pb0.001) and working memory span (r=0.44,
pb0.001) but not with the remaining variables (range of
rs=0.05–0.22). At one-year follow-up, current IQ was sig-
niﬁcantly correlated with recognition memory (r=0.47,
pb0.001), working memory manipulation (r=0.37, p=0.005),
workingmemory span (r=0.40, p=0.003), set shifting (r=0.46,
pb0.001), rule learning (r=0.29, p=0.033), planning (r=0.30,
p=0.026) but not thinking time (r=0.01, p=0.921).
The results of the main regression analyses are shown in
Table 2. After entry of initial SFS score, a signiﬁcant amount
(24%) of the remaining variance in four-year SFS score was
explained by IQ and thinking time at the initial assessment. IQ
and thinking time predicted the SFS subscale score of
activation-engagement, explaining 23% of the variance. IQ
alone predicted frequency of activities of daily living (19%
variance) and occupational activity (16% variance). Thirty-two
percent of the variance in interpersonal communication was
explained by a number of neuropsychological measures
including IQ and thinking time. When neuropsychological
measures at one-year follow-up were used, IQ was the sole
predictor of global social function (12% variance) and themain
predictor of frequency of activities of daily living and
occupational activity.
There were no consistent predictors of symptoms at four-
year follow-up. IQ, thinking time and recognition memory at
initial assessment together predicted 50% of the variance in
the negative syndrome, whereas thinking time alone pre-
dicted the positive syndrome (14% variance) and recognition
memory alone the disorganisation syndrome (25% variance).
One-year follow-up measures showed a different predictive
pattern, with set-shifting predicting negative symptoms (10%
variance) and planning predicting disorganisation (15%
variance).
We also examined the predictive values of premorbid and
concurrent IQ using regression analysis, and found that both
variables signiﬁcantly contributed to global four-year social
function (premorbid IQ: r2adj=0.08, t=2.40, p=0.021; four-year
IQ: r2adj=0.12, t=4.72, p=0.014). The presence of the negative
syndrome at four-year follow-up was also predicted by four-
year IQ (Wald=5.14, p=0.023, odds ratio=0.95 Nagelkerke
r2=0.17) but not by premorbid IQ (Wald=0.50, p=0.478,
Nagelkerke r2=0.02). Verbal and performance IQ were addi-
tionally examined independently to assess the contribution of
verbal and non-verbal skills. Using a prorated score based on
the two subtests from either the performance or verbal tests at
initial assessment, both were signiﬁcant predictors of global
four-year social function (verbal IQ: r2adj =0.19, t=3.38,
p=0.002; performance IQ: r2adj=0.13, t=2.84, p=0.007).
Finally, because other studies have reported that a
proportion of the variance in follow-up social functioning is
accounted for by symptomsmeasured at an earlier time point,
we tested whether including symptom variables in the model
prior to testing for the relative contribution of neuropsycho-
logical measures had an effect. We performed an hierarchicallinear regression with four-year follow-up SFS scale score as
the dependent variable, all three syndrome scores at ﬁrst
episode entered into the ﬁrst block as predictors and current
IQ at ﬁrst episode entered into the second block. The results
showed that IQ continued to explain a signiﬁcant additional
proportion of the variance once the inﬂuence of syndrome
scores was accounted for (r2adj=0.13, t=3.08, p=0.003). A
similar analysis with age at illness onset and sex entered in
the ﬁrst block also showed IQ to remain a signiﬁcant predictor
(r2adj=0.30, t=4.180, pb0.001).
4. Discussion
One of the aims of this study was to determine whether
general or speciﬁc aspects of cognitive function early in the
course of schizophrenia predicted later social and clinical
outcomes. We examined the effect of IQ and seven indices of
memory and executive function on social function a mean of
four years after ﬁrst presentation with psychosis. Social
function was measured with the SFS which assesses seven
domains of social activity and also provides a global index of
social function (Birchwood et al., 1990). Of the cognitive
measures used, IQ and thinking time at illness onset were the
only predictors of global social function and these accounted
for 24% of the variance. These two measures also uniquely
predicted the domain of activation-engagement and con-
tributed to the prediction of interpersonal communication. IQ
alone predicted the frequency of activities of daily living and
occupational activity. Although more speciﬁc measures of
cognitive function also made contributions to various social
domains, these associations were weaker and less consistent
than those with IQ. We checked that this was not due to the
fact that the memory and executive measures were all non-
verbal by examining prorated verbal and performance IQ
scores independently. Both were strong predictors of four-
year global social function indicating that the IQ effect
reﬂected general ability incorporating both verbal and non-
verbal skills.
In relation to ﬁrst-episode psychosis, Addington et al.
(2005) have argued that cognitive function after one year is a
more appropriate baseline fromwhich to assess predictors of
outcome, as any ﬂuctuations due to a disturbed mental state
should be less evident at this time. Accordingly, we
substituted the same variables measured at one-year fol-
low-up for those at ﬁrst episode and repeated the analysis. IQ
at one-year follow-up predicted global social function and
contributed to two of the four social function domains
predicted by IQ at illness presentation, namely frequency of
activities of daily living and occupational activity. Of the
speciﬁc cognitive functions, no single variable more reliably
or more strongly predicted social outcome than IQ, although
working memory manipulation predicted three of the seven
domains of social function on this occasion.
Several studies have failed to ﬁnd any association between
cognitive function and social function assessed at different
times over the ﬁrst 10 years of psychotic illness (Malla et al.,
2002; Stirling et al., 2003; Verdoux et al., 2002). Others have
found associations between speciﬁc aspects of cognition
and social function (Holthausen et al., 2003; Milev et al.,
2005). Studies which combined different neuropsychological
measures to derive a composite cognitive score are also
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Holthausen et al., 2007; Robinson et al., 2004; Stirling et al.,
2003). In our study, the predictive values of individual
measures of cognitive function were generally weak and
there were changes in the measures predicting speciﬁc
domains of social function between ﬁrst assessment and
one-year follow-up. These ﬁndings suggest that speciﬁc
neuropsychological domain measures in the early stages of
schizophrenia are unreliable predictors of later social
outcome.
Few ﬁrst-episode studies have assessed the impact of IQ
on later social function (Carlsson et al., 2006; Malla et al.,
2002; van Winkel et al., 2007), and to our knowledge ours is
the only one to examine the predictive value of IQ and speciﬁc
cognitive functions at more than one time point following
psychosis onset. Malla et al. (2002) and Carlsson et al. (2006),
in mixed groups of schizophrenia and non-schizophrenia
patients, did not ﬁnd a predictive relationship between IQ at
ﬁrst episode and social function one year later. The study by
Carlsson et al. (2006) also assessed three-year outcome and,
on this occasion, found that ﬁrst-episode IQ differentiated
those with good and poor social function. Along with our
ﬁnding that IQ predicted social function at four-year follow-
up, this suggests that it is possible to predict medium term
social outcome using IQ. However social function in the ﬁrst
year of psychotic illness may well be unstable making it
difﬁcult to determine true relationships with any measure of
cognition, including IQ.
van Winkel et al. (2007) suggested that IQ at illness onset
is an unreliable predictor of social outcome and that
premorbid IQ and IQ at the time of outcome assessment are
better predictors. However, whilst we conﬁrmed that pre-
morbid and concurrent IQ are signiﬁcant predictors of social
function, our results indicate that IQ at ﬁrst presentation and
also at one-year follow-up can be used to predict later social
function. Taken together the ﬁndings suggest that IQ is both a
sensitive cognitive predictor of outcome and a stable trait
impacting on function early in the course of schizophrenia.
Previous ﬁrst-episode studies have found that when both
neuropsychological test scores and symptoms were included
in regression analyses, the predictive value of various
cognitive measures became greatly reduced (Addington
et al., 2005; Milev et al., 2005). We examined this possibility
by performing a regression analysis which entered initial
positive, negative and disorganisation syndrome scores ahead
of IQ and found that the predictive effect of IQ was
unchanged. Thus the relationship between IQ and later social
function did not appear to be a proxy for the association
between symptoms and social function; IQ predicted a unique
part of the variance in social outcome, regardless of any
predictive inﬂuence of symptoms on this outcome.
The relationships between neuropsychological perfor-
mance and the presence of residual symptoms at four-year
follow-up were also examined. The most consistent ﬁnding
was that IQ predicted the presence of the negative syndrome,
although this was found only using ﬁrst assessment and
concurrent measures of IQ. Other studies have reported
similar relationships. Carlsson et al. (2006) found that IQ
predicted negative symptoms at one-year although not three-
year follow-up assessment, and Stirling et al. (2003) found
that a measure of general cognitive ability that was largelycomprised of WAIS subtest measures predicted negative
symptom severity 10 years later. Thus, in addition to social
function, IQ appears also to be relevant to the persistence or
later development of negative symptoms but the ﬁndings are
less consistent.
The amount of the variance explained by IQ was relatively
small, ranging from 12% to 17% for current IQ and 8% for
premorbid IQ; only the measure of thinking time added any
greater predictive value to the model from the measures we
employed. However, the size of our effects is similar to or
greater than that reported in other studies of ﬁrst-episode
psychosis using different measures. Further, despite the
modest percentage of variance explained, our ﬁndings
suggest that IQ is a measure which can consistently predict
later social and clinical outcome in patients with ﬁrst-episode
schizophrenia and, in this context, is better than measures of
speciﬁc abilities.
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